Abstract:An OV‐rich heterojunction SBN/SNO‐PEG NCs is engineered in this study. Under the trigger of US, the internal EF in the PEMs and in the heterojunction region field induces the continuous separation of e−‐h+ pairs, leading to the augmented production of ROS. Concurrently, the surface OVs adsorb and activate O2 to further boost ROS generation. This process amplifies the sonopiezoelectric effect and drives the apoptosis of tumor cells through the mitochondrial pathway, thus achieving a potent inhibitory effect against HCC. Using piezoelectric bionanomaterials to promote the generation of reactive oxygen species (ROS) is being increasingly recognized in ultrasound (US)‐triggered tumor treatments. The mechanism underlying this innovative treatment involves US irradiation, which activates the built‐in electric field (BIEF) and induces energy‐band bending in piezoelectric materials (PEMs). In this study, Sr0.5Ba0.5Nb2O6 (SBN) nanorods (NRs) are synthesized using a molten salt method. Subsequently, oxygen‐vacancy (OV)‐rich SBN/Sr2Nb2O7 (SBN/SNO) heterojunction nanocomposites (NCs) are fabricated via H2 annealing of the SBN NRs. The engineering strategy focused on enhancing ROS generation, thereby augmenting the piezoelectric catalytic activity of the NCs. This configuration ensures that the BIEF and heterojunction‐induced field act synergistically to provide a sustained driving force for the separation of electron‐hole (e−‐h+) pairs. Importantly, the OVs on the surfaces of the H2‐annealed SBN NRs create electron‐rich sites, which substantially enhance their piezocatalytic capabilities. In vitro and in vivo analyses of hepatocellular carcinoma (HCC) models demonstrate the significant cytotoxic and tumor‐inhibitory capabilities of this rich OV‐mediated sonopiezoelectric therapy (SPT) and illustrate its potential as a promising therapeutic approach against cancer.

Piezoelectric Analgesia Blocks Cancer‐Induced Bone Pain

Optimized Piezoelectric Bone Regeneration Through Inhibiting Sympathetic Nerve-Bone Interaction

Brain‐derived Neurotrophic Factor Modulates N‐methyl‐D‐aspartate Receptor Activation in a Rat Model of Cancer‐induced Bone Pain

Engineering 2D Bi4NbO8Br single crystalline nanosheets for piezoelectric and piezodynamic tumor nanotherapy

Blocking Cancer-Nerve Crosstalk for Treatment of Metastatic Bone Cancer Pain.

Ion channels in cancer-induced bone pain: from molecular mechanisms to clinical applications

Dorsal root ganglia NR2B-mediated Epac1-Piezo2 signaling pathway contributes to mechanical allodynia of bone cancer pain

PGC‐1α activation ameliorates cancer-induced bone pain via inhibiting apoptosis of GABAergic interneurons

LY294002 alleviates bone cancer pain by reducing mitochondrial dysfunction and the inflammatory response

Functional up-regulation of P2X3 receptors in dorsal root ganglion in a rat model of bone cancer pain

Bone-Inspired Spatially Specific Piezoelectricity Induces Bone Regeneration

Neurophysiological mechanisms of cancer-induced bone pain

Cav3.2 T-Type calcium channels downregulation attenuates bone cancer pain induced by inhibiting IGF-1/ HIF-1α signaling pathway in the rat spinal cord

Targeting A-type K(+) Channels in Primary Sensory Neurons for Bone Cancer Pain in a Rat Model.

Enhanced Function of TRPV1 Via Up-Regulation by Insulin-Like Growth Factor-1 in a Rat Model of Bone Cancer Pain.

Novel therapies for cancer-induced bone pain

Engineering Heterostructured Piezoelectric Nanorods with Rich Oxygen Vacancy‐Mediated Piezoelectricity for Ultrasound‐Triggered Piezocatalytic Cancer Therapy

Piezoelectric Nanomaterials Activated by Ultrasound in Disease Treatment

Minocycline‐induced Reduction of Brain‐derived Neurotrophic Factor Expression in Relation to Cancer‐induced Bone Pain in Rats

Emerging Advancements in Piezoelectric Nanomaterials for Dynamic Tumor Therapy

Piezoelectric Ba0.85Sr0.15TiO3 Nanosonosensitizer with Nitric Oxide Delivery for Boosting Cancer Therapy